Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Nov 05, 2021 1:31pm
341 Views
Post# 34093033

RE:RE:RE:Politics Aside

RE:RE:RE:Politics Aside

It all depends on what data the Principal Investigator shares with Theralase and how much data was collected.  As of August 30, they had treated an additional 6 patients on which we have not seen data yet.  So November 30 is 90 days  data collection is 90 days +/- 7 days so it could be that we get an update on up to 6 patients #´s 19, 20, 21, 22, 23 and 24.  I'm hoping that this is why they waited until end of November, or at least also have had the time to get a decent amount of new patients treated.  All IMO time will tell.


DJDawg wrote:
Sounds good Enrique. Is it my understanding that we would be expecting data back on 6 with the end November update? Does that timeline work? I have trouble keep track.

 

<< Previous
Bullboard Posts
Next >>